From: Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II
 | Cases (n= 613) | Controls (n= 1,218) |
---|---|---|
Age at blood collection, y | 45.0 ± 4.4 | 44.9 ± 4.4 |
Age at menarche, y | 12.4 ± 1.3 | 12.4 ± 1.4 |
BMI at age 18, kg/m² | 20.7 ± 2.9 | 21.1 ± 3.0 |
BMI at blood collection, kg/m² | 25.5 ± 6.3 | 26.3 ± 7.1 |
Weight change since age 18, kg | 11.6 ± 12.1 | 12.8 ± 13.8 |
Ever used oral contraceptives % | 86 | 86 |
Duration of past oral contraceptives use, months* | 47.4 ± 46.9 | 45.8 ± 45.6 |
Nulliparous, % | 22 | 20 |
Parity, children†| 2.2 ± 0.9 | 2.3 ± 0.9 |
Age at first birth, y†| 26.6 ± 4.6 | 26.3 ± 4.6 |
Ever breast fed, %†| 78 | 80 |
Premenopausal at blood collection, % | 77 | 76 |
Family history of breast cancer, % | 17 | 10 |
History of benign breast disease, % | 23 | 16 |
Plasma 25(OH)D level, ng/mL (nmol/L) | 25.4 (63.4) ± 9.5 (23.7) | 25.0 (62.4) ± 9.6 (24.0) |
Time from blood collection to diagnosis, months | 57.4 ± 33.5 | NA |